6 Roles and Responsibilities of the Department of Health in the Management of Medication for Termination of Pregnancy (Mifepristone and Misoprostol Packaged Together)

After mifepristone and misoprostol packaged in the same panel were registered in December 2014, the Food and Drug Administration requested the Department of Health, Ministry of Public Health, to manage mifepristone and misoprostol packaged in the same panel to perform the management and closely monitor the use of the drugs for 2 years.The following tasks are to be performed:

1. Coordinate with healthcare facilities both within and outside the Ministry of Public Health to assess readiness to provide services and authorize the provision of mifepristone and misoprostol in abortion services.
2. Prepare a manual for the use of mifepristone and misoprostol and distribute the manual to various healthcare facilities that provide the drugs.
3. Collect reports of mifepristone and misoprostol imported by pharmaceutical import and distribution companies.
4. Collect and analyze the administration of drugs and abortion from reports of various healthcare facilities.
5. Monitor and track adverse side effects from drug use.
6. Coordinate with pharmaceutical import companies to prepare statistical progress reports every 4 months and submit them to the Food and Drug Administration, Ministry of Public Health.

Purchasing abortion pills online is risky. There is no quality assurance, not under medical supervision, you may be deceived, not receive the drugs, or receive drugs that are of poor quality, counterfeit drugs, use the drugs and fail to induce abortion, receive incorrect drug dosage. Most websites tend to sell more drugs according to the gestational age, which is incorrect information and not in accordance with treatment guidelines, leading to complications and infections from drug use, which can be as severe as uterine rupture and death.